These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8249432)

  • 61. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
    Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
    Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Evaluation of adjuvant effects of fucoidane from brown seaweed Fucus evanescens and its structural analogues for the strengthening vaccines effectiveness].
    Kuznetsova TA; Ivanushko LA; Persiyanova EV; Shutikova AL; Ermakova SP; Khotimchenko MY; Besednova NN
    Biomed Khim; 2017 Nov; 63(6):553-558. PubMed ID: 29251618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens.
    Singh M; Ugozzoli M; Kazzaz J; Chesko J; Soenawan E; Mannucci D; Titta F; Contorni M; Volpini G; Del Guidice G; O'Hagan DT
    Vaccine; 2006 Mar; 24(10):1680-6. PubMed ID: 16300864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Vaccination with three HIV-1 cross neutralizing epitopes fused to HBV S antigen could induce robust antibody immune response in mice].
    Li XR; Chen H; Wang W; Deng Y; Qi XR; Gao YY; Meng X; Tan WJ; Ruan L
    Bing Du Xue Bao; 2008 Jul; 24(4):260-7. PubMed ID: 18780627
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide.
    Wang P; Devalankar DA; Dai Q; Zhang P; Michalek SM
    J Org Chem; 2016 Oct; 81(20):9560-9566. PubMed ID: 27709937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice.
    Weeratna R; Comanita L; Davis HL
    Immunol Cell Biol; 2003 Feb; 81(1):59-62. PubMed ID: 12534947
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH; Lloyd JP; Heisey D; Winship MD; Siwek M; Talor E; Sarin PS
    Vaccine; 2001 Sep; 19(32):4750-9. PubMed ID: 11535326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
    Fast DJ; Vosika GJ
    Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Poliovirus-induced immunosuppression in mice and the possibilities for its correction].
    Shirobokov VP; Giulling EV; Korniushenko ON; Negrebetskaia EN; Rozenfel'd OL
    Mikrobiol Zh (1978); 1986; 48(1):86-90. PubMed ID: 2855844
    [No Abstract]   [Full Text] [Related]  

  • 75. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
    Buchanan RM; Arulanandam BP; Metzger DW
    J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
    Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.
    Chow M; Yabrov R; Bittle J; Hogle J; Baltimore D
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):910-4. PubMed ID: 2983321
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Myelopeptide-1 stimulates humoral immune response in irradiated mice].
    Shanurin SIu
    Radiats Biol Radioecol; 1994; 34(4-5):509-13. PubMed ID: 7951877
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
    Weeratna RD; Makinen SR; McCluskie MJ; Davis HL
    Vaccine; 2005 Nov; 23(45):5263-70. PubMed ID: 16081189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
    Sanders H; Feavers IM
    Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.